TP53 and neoplasm: Certain hereditary syndromes, such as Li-Fraumeni Syndrome (TP53 mutations) and Neurofibromatosis Type 1 (NF1 mutations), significantly increase glioma risk by disrupting tumor suppressor pathways [5].